abstract |
The disclosure relates to a compound having Formula (I′): n n n n n n n n n n andn nin particular, Compound I-126:n n n n n n n n n n n which modulates the activity of EGFR, a pharmaceutical composition comprising the compound, and a method of treating or preventing a disease in which EGFR plays a role. |